This document presents a study on the determination of methylxanthines (caffeine, theobromine, and theophylline) in cocoa, coffee, and tea using HPLC. The author develops and validates an HPLC method for extracting and analyzing the methylxanthine content of different samples. Results show theobromine is mainly present in cocoa, caffeine is abundant in coffee, and only trace amounts of theophylline are found in the three samples. Gas chromatography-mass spectrometry is also used to identify methylxanthines and observe their fragmentation patterns.
Adrenergic blocking agents, also known as adrenergic antagonists, block alpha and/or beta receptor sites and have the opposite effect of adrenergic agents. They are classified based on the type of adrenergic receptor they block, including alpha1, alpha2, beta1, beta2, and beta3 receptors. Common uses include treatment of hypertension, heart failure, and benign prostatic hyperplasia. Side effects may include hypotension, tachycardia, and bronchospasm.
This document discusses opioid analgesics, including their classification, mechanisms of action, and effects. It begins by defining analgesics, opioids, opiates, and narcotics. It then discusses the opioid morphine in depth, including its pharmacological effects in the central nervous system and peripherally. Other opioids discussed include pethidine, methadone, tramadol, endogenous opioid peptides, and opioid receptor antagonists such as naloxone. The document provides an overview of the classification, properties, uses, and adverse effects of various opioid analgesics.
Anti Tubercular Drugs - Mechanism of Action and Adverse effects Thomas Kurian
A brief outline of the mechanism of action and adverse effects of anti tubercular drugs
Only First line and second line drugs are dealt with.First line drugs may be useful for MBBS students and the rest is directed for postgraduate students.
Hope you find it useful.
This document summarizes various opioid agonists and antagonists. It discusses natural and synthetic opioids like morphine, codeine, heroin, hydromorphone, fentanyl, meperidine, methadone, and diphenoxylate. It also covers opioid receptors, endogenous opioid peptides, pharmacokinetics, effects, tolerance, toxicity, and antagonists like naloxone and naltrexone. Non-steroidal anti-inflammatory drugs are also briefly mentioned.
This document discusses histamine and antihistamine drugs. It begins by introducing histamine as a biogenic amine involved in inflammatory and hypersensitivity reactions. Histamine is synthesized from the amino acid histidine and stored in mast cells. It is involved in processes like gastric acid secretion and allergic responses. Antihistamines work by blocking the action of histamine at receptors. First generation antihistamines are more sedating while second generation ones have less side effects. Common antihistamines and their uses in conditions like allergies and vertigo are described. The document provides an overview of histamine function and the mechanisms of antihistamine drugs.
Anticonvulsants are medications used to treat seizures and epilepsy. They work by enhancing the inhibitory neurotransmitter GABA, inhibiting sodium or calcium channels, or other mechanisms. Common anticonvulsants discussed include carbamazepine, phenytoin, lamotrigine, ethosuximide, phenobarbital, valproate, and benzodiazepines like diazepam. Each drug has specific indications, mechanisms of action, dosing regimens, side effects, and contraindications.
Theophylline is a bronchodilator used to treat respiratory conditions like asthma and COPD. It works by inhibiting phosphodiesterase and antagonizing adenosine receptors to relax smooth muscle. It has a narrow therapeutic window and can cause side effects like nausea, vomiting, arrhythmias and seizures if levels are too high. Special care must be taken with dosing in children, elderly, and those with liver or kidney problems. Smoking may increase its metabolism and require higher doses to maintain therapeutic levels.
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter synthesized from tryptophan. It is present mainly in the gastrointestinal tract and blood platelets, with some in the central nervous system. Serotonin acts through multiple receptor subtypes and has diverse physiological effects including regulation of mood, appetite, sleep, and cardiovascular and gastrointestinal functions. Antagonists of serotonin receptors are used to treat conditions like migraine, hypertension, nausea/vomiting, and carcinoid syndrome. Common antagonists include cyproheptadine, ketanserin, ondansetron, and ergot alkaloids.
Adrenergic blocking agents, also known as adrenergic antagonists, block alpha and/or beta receptor sites and have the opposite effect of adrenergic agents. They are classified based on the type of adrenergic receptor they block, including alpha1, alpha2, beta1, beta2, and beta3 receptors. Common uses include treatment of hypertension, heart failure, and benign prostatic hyperplasia. Side effects may include hypotension, tachycardia, and bronchospasm.
This document discusses opioid analgesics, including their classification, mechanisms of action, and effects. It begins by defining analgesics, opioids, opiates, and narcotics. It then discusses the opioid morphine in depth, including its pharmacological effects in the central nervous system and peripherally. Other opioids discussed include pethidine, methadone, tramadol, endogenous opioid peptides, and opioid receptor antagonists such as naloxone. The document provides an overview of the classification, properties, uses, and adverse effects of various opioid analgesics.
Anti Tubercular Drugs - Mechanism of Action and Adverse effects Thomas Kurian
A brief outline of the mechanism of action and adverse effects of anti tubercular drugs
Only First line and second line drugs are dealt with.First line drugs may be useful for MBBS students and the rest is directed for postgraduate students.
Hope you find it useful.
This document summarizes various opioid agonists and antagonists. It discusses natural and synthetic opioids like morphine, codeine, heroin, hydromorphone, fentanyl, meperidine, methadone, and diphenoxylate. It also covers opioid receptors, endogenous opioid peptides, pharmacokinetics, effects, tolerance, toxicity, and antagonists like naloxone and naltrexone. Non-steroidal anti-inflammatory drugs are also briefly mentioned.
This document discusses histamine and antihistamine drugs. It begins by introducing histamine as a biogenic amine involved in inflammatory and hypersensitivity reactions. Histamine is synthesized from the amino acid histidine and stored in mast cells. It is involved in processes like gastric acid secretion and allergic responses. Antihistamines work by blocking the action of histamine at receptors. First generation antihistamines are more sedating while second generation ones have less side effects. Common antihistamines and their uses in conditions like allergies and vertigo are described. The document provides an overview of histamine function and the mechanisms of antihistamine drugs.
Anticonvulsants are medications used to treat seizures and epilepsy. They work by enhancing the inhibitory neurotransmitter GABA, inhibiting sodium or calcium channels, or other mechanisms. Common anticonvulsants discussed include carbamazepine, phenytoin, lamotrigine, ethosuximide, phenobarbital, valproate, and benzodiazepines like diazepam. Each drug has specific indications, mechanisms of action, dosing regimens, side effects, and contraindications.
Theophylline is a bronchodilator used to treat respiratory conditions like asthma and COPD. It works by inhibiting phosphodiesterase and antagonizing adenosine receptors to relax smooth muscle. It has a narrow therapeutic window and can cause side effects like nausea, vomiting, arrhythmias and seizures if levels are too high. Special care must be taken with dosing in children, elderly, and those with liver or kidney problems. Smoking may increase its metabolism and require higher doses to maintain therapeutic levels.
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter synthesized from tryptophan. It is present mainly in the gastrointestinal tract and blood platelets, with some in the central nervous system. Serotonin acts through multiple receptor subtypes and has diverse physiological effects including regulation of mood, appetite, sleep, and cardiovascular and gastrointestinal functions. Antagonists of serotonin receptors are used to treat conditions like migraine, hypertension, nausea/vomiting, and carcinoid syndrome. Common antagonists include cyproheptadine, ketanserin, ondansetron, and ergot alkaloids.
This document discusses antigout drugs used to treat gout. It begins by defining gout as a metabolic disease caused by increased uric acid levels in the blood. It then describes the mechanisms and classifications of various antigout drugs including allopurinol, probenecid, sulfinpyrazone, corticosteroids, NSAIDs, and colchicine. For each drug, it discusses their mechanisms of action, pharmacokinetics, uses, interactions, toxicity, and administration guidelines for treating both acute and chronic gout. The document provides an in-depth overview of different drug classes used to manage hyperuricemia and gouty arthritis.
Histamine is a chemical messenger that mediates allergic and inflammatory reactions. It is synthesized and stored in mast cells and basophils before being released in response to stimuli. Histamine binds to H1, H2, H3, and H4 receptors, with the H1 and H2 receptors being clinically relevant drug targets. Antihistamines are used to treat allergic conditions by blocking H1 receptors, and H2 receptor blockers inhibit gastric acid secretion. First-generation antihistamines have greater sedative and anticholinergic side effects than second-generation drugs due to interactions with other receptors.
This document discusses tuberculosis (TB) and its treatment. It provides background on TB prevalence in India and the evolution of TB treatment programs in the country. It describes the mechanisms and kinetics of first-line and second-line TB drugs. It discusses the development of drug resistance and optimal treatment regimens. The goal of TB treatment is to kill actively dividing bacilli, eliminate persistent bacilli to sterilize the patient, and prevent emergence of drug resistance. Current short course multidrug regimens following DOTS guidelines aim to achieve these goals in 6-8 months.
Antiarrhythmic drugs are used to treat and prevent cardiac arrhythmias by blocking ion channels involved in cardiac impulse generation and conduction. Class I drugs like quinidine and procainamide block sodium channels to prolong the action potential duration, while Class IB drugs like lignocaine shorten repolarization. Class III drugs like amiodarone block potassium channels to prolong the action potential. Calcium channel blockers like verapamil inhibit calcium influx. Other drugs include adenosine for paroxysmal supraventricular tachycardia, beta blockers for supraventricular arrhythmias, and atropine for bradycardias. Adverse effects vary between drugs but include arrhythmias, heart block and QT prolong
There are two main types of neuromuscular blockers: competitive antagonists like curare and depolarizing blockers like succinylcholine. Competitive antagonists work by competitively binding to nicotinic receptors at the neuromuscular junction, while depolarizing blockers cause sustained depolarization of the end plate. Neuromuscular blockers differ in their mechanism of action, duration and speed of onset/offset, selectivity, and side effect profiles. Common examples include succinylcholine, atracurium, pancuronium and vecuronium.
Narcotics and Non-Narcotics Analgesics.pptxFarazaJaved
This document summarizes narcotic and non-narcotic analgesics. It describes major classes of analgesics including opioids, NSAIDs, acetaminophen, flupirtine, and ziconotide. Specific drugs are discussed including morphine, methadone, fentanyl, codeine, tramadol, acetaminophen, NSAIDs, flupirtine and ziconotide. Their mechanisms of action, uses, adverse effects, and classification as pure agonists, partial agonists, antagonists are summarized.
Hyperlipidemia is a common disorder caused by abnormalities in lipid metabolism or transport. It results in high levels of lipids like cholesterol and triglycerides in the blood. Hyperlipidemia is classified based on the abnormal lipid levels and is primarily treated through lifestyle changes and medications that lower lipid levels. Common drug classes used to treat hyperlipidemia work by inhibiting cholesterol synthesis, breaking down fats, or blocking lipid absorption.
Drugs acting on Renin Angiotensin Aldosterone system Dr Htet
This document discusses drugs that act on the renin-angiotensin-aldosterone system (RAA system). It describes the RAA system and lists the main drug classes: renin inhibitors, ACE inhibitors, angiotensin receptor blockers, and aldosterone antagonists. For each drug class, it covers the mechanism of action, pharmacological effects, clinical uses, and adverse effects. The key drugs discussed are aliskiren, various ACE inhibitors like enalapril and lisinopril, angiotensin receptor blockers like losartan and valsartan, and aldosterone antagonists spironolactone and eplerenone.
Sulfonylureas are oral hypoglycemic drugs that enhance insulin secretion from the pancreas. They work by blocking ATP-sensitive potassium channels in pancreatic beta cells, which leads to insulin release. Common side effects include hypoglycemia and weight gain. Examples include glibenclamide, glipizide, and glimepiride. Choice of sulfonylurea depends on factors like duration of action, renal function, and patient age. They are generally effective treatments for type 2 diabetes but require caution in elderly patients or those with kidney/liver problems.
This document discusses angiotensin receptor blockers (ARBs) which are used to treat hypertension and other cardiovascular conditions. It notes that ARBs work by competitively blocking the angiotensin receptor type 1, leading to vasodilation and other effects. Some examples of individual ARB drugs are provided like losartan, candesartan, and valsartan. The document compares ARBs to ACE inhibitors, noting that ARBs do not cause cough like ACE inhibitors. It concludes by discussing the theoretical rationale and benefits of combining ARBs with ACE inhibitors to more completely suppress the renin-angiotensin system.
PPt on Opioid Analgesics for paramedical students (BPT/BSc Nursing)Dhruva Sharma
- Morphine is the prototypical opioid analgesic extracted from the opium poppy. It acts primarily on mu-opioid receptors in the central nervous system to produce analgesia.
- Morphine administration results in pain relief, sedation, respiratory depression, constipation, and a risk of tolerance and physical dependence developing with chronic use.
- While morphine remains a gold standard for pain treatment, its use requires precautions around side effects like respiratory depression, especially in high-risk groups such as infants, the elderly, and those with respiratory conditions.
Histamine and bradykinin are important autacoids or local hormones that act near their site of synthesis to exert physiological effects. Histamine is released from mast cells and basophils during allergic reactions and binds to H1, H2, H3 and H4 receptors, causing effects like vasodilation, increased vascular permeability, and bronchioconstriction. It is involved in allergic diseases. Bradykinin is produced from kininogen and acts on B1 and B2 receptors to cause vasodilation, smooth muscle contraction, increased vascular permeability and pain. Both histamine and bradykinin are inactivated by enzymatic degradation and their effects can be blocked by receptor antagonists.
This document discusses antiarrhythmic drugs used to treat irregular heart rhythms or arrhythmias. It describes the mechanisms that can cause arrhythmias such as enhanced pacemaker activity, after-depolarizations, and reentry. It then covers the major classes of antiarrhythmic drugs including class I sodium channel blockers, class II beta blockers, class III potassium channel blockers, and class IV calcium channel blockers. Specific drugs from each class are discussed, how they work, their therapeutic uses, and potential side effects. Common arrhythmias like atrial fibrillation, atrial flutter, and ventricular tachycardia are also defined.
Pharmacotherapy of Chronic Obstructive Pulmonary DiseaseTsegaye Melaku
A 58-year-old man with COPD and hypertension is admitted to the hospital for an exacerbation of his COPD. He is treated with oxygen, bronchodilators, corticosteroids, and antibiotics. The goals of COPD treatment are to reduce symptoms, improve quality of life and exercise tolerance, and prevent exacerbations and hospitalizations through pharmacologic and non-pharmacologic therapies like smoking cessation, vaccination, pulmonary rehabilitation, and in severe cases, long-term oxygen therapy or surgery. Proper diagnosis involves assessing symptoms, risk factors, and using spirometry to confirm persistent airflow limitation.
General Anaesthesia produces reversible loss of sensation and consciousness through the use of drugs. There are two main classifications of anaesthetics - inhalational and intravenous. Inhalational includes gases like nitrous oxide and liquid anaesthetics administered using a vaporizer. Intravenous anaesthetics include inducing agents like thiopentone sodium and propofol, as well as slower acting drugs like ketamine and benzodiazepines. Anaesthesia involves three stages - induction, maintenance, and recovery. The ideal stage for surgery is stage III, where there is loss of muscle tone and reflexes. Careful monitoring is needed to prevent progression to stage IV, which can cause respiratory and circulatory depression.
Phenytoin is an anti-seizure medication that works by blocking voltage-gated sodium channels in neurons. It has nonlinear pharmacokinetics and a narrow therapeutic index. Common side effects include gingival hyperplasia and nystagmus. Serious potential side effects include bone marrow suppression, low blood pressure, and Stevens-Johnson syndrome. It must be carefully monitored due to risks of toxicity at high doses.
Barbiturates are derivatives of barbituric acid that act as central nervous system depressants. They have multiple mechanisms of action in the brain involving GABA receptors and ion channels. Barbiturates are classified based on their duration of action and include long, intermediate, short, and ultrashort-acting varieties. While once widely used as sedatives, hypnotics, and for anesthesia, barbiturates have significant disadvantages like low therapeutic index, drug interactions, abuse potential, and severe withdrawal syndrome. Newer agents like benzodiazepines, buspirone, zolpidem, and zaleplon have replaced barbiturates for most indications due to safer profiles
This presentation was given by me during my M.pharm.
It contains description, classification, mechanism of actions and therapeutic uses of Neuromuscular blockers.
Local anesthetics reversibly depress the central nervous system to relieve pain without loss of consciousness. They work by binding to voltage-gated sodium channels in nerve cell membranes, inhibiting the generation of action potentials and reducing nerve excitability. Local anesthetics are classified as amides or esters depending on their chemical structure. Amides are more stable but esters have a faster onset of action. Both types contain an aromatic ring connected by an amide or ester linkage to a hydrophilic amine group, allowing them to penetrate cell membranes. The presence of electron-withdrawing groups on the aromatic ring and lipophilic chains influence their potency and duration. Common applications of local anesthetics include dentistry, dermat
This document summarizes the presentation of a research article on the development and validation of an RP-HPLC method for the simultaneous determination of metformin and evogliptin in pharmaceutical formulations. The method was developed using a C18 column with an isocratic mobile phase of methanol and water at pH 3. Both drugs showed good separation and were detected at 254 nm. The method was validated and found to be linear, precise, accurate, robust, and specific for quantifying the drugs in tablets within 3 minutes. The method can be applied for routine quality control analysis of metformin and evogliptin combinations.
1) The co-op student worked at Bristol-Myers Squibb to optimize protein purification chromatography conditions and improve impurity clearance.
2) High-throughput screening was used to evaluate different buffer and resin combinations. Process conditions were optimized to separate variants and improve purity.
3) The student met project goals including developing chromatography methods, characterizing protein populations, and providing insights into improving processes. The work focused on optimizing the initial protein A capture step to reduce downstream purification needs.
This document discusses antigout drugs used to treat gout. It begins by defining gout as a metabolic disease caused by increased uric acid levels in the blood. It then describes the mechanisms and classifications of various antigout drugs including allopurinol, probenecid, sulfinpyrazone, corticosteroids, NSAIDs, and colchicine. For each drug, it discusses their mechanisms of action, pharmacokinetics, uses, interactions, toxicity, and administration guidelines for treating both acute and chronic gout. The document provides an in-depth overview of different drug classes used to manage hyperuricemia and gouty arthritis.
Histamine is a chemical messenger that mediates allergic and inflammatory reactions. It is synthesized and stored in mast cells and basophils before being released in response to stimuli. Histamine binds to H1, H2, H3, and H4 receptors, with the H1 and H2 receptors being clinically relevant drug targets. Antihistamines are used to treat allergic conditions by blocking H1 receptors, and H2 receptor blockers inhibit gastric acid secretion. First-generation antihistamines have greater sedative and anticholinergic side effects than second-generation drugs due to interactions with other receptors.
This document discusses tuberculosis (TB) and its treatment. It provides background on TB prevalence in India and the evolution of TB treatment programs in the country. It describes the mechanisms and kinetics of first-line and second-line TB drugs. It discusses the development of drug resistance and optimal treatment regimens. The goal of TB treatment is to kill actively dividing bacilli, eliminate persistent bacilli to sterilize the patient, and prevent emergence of drug resistance. Current short course multidrug regimens following DOTS guidelines aim to achieve these goals in 6-8 months.
Antiarrhythmic drugs are used to treat and prevent cardiac arrhythmias by blocking ion channels involved in cardiac impulse generation and conduction. Class I drugs like quinidine and procainamide block sodium channels to prolong the action potential duration, while Class IB drugs like lignocaine shorten repolarization. Class III drugs like amiodarone block potassium channels to prolong the action potential. Calcium channel blockers like verapamil inhibit calcium influx. Other drugs include adenosine for paroxysmal supraventricular tachycardia, beta blockers for supraventricular arrhythmias, and atropine for bradycardias. Adverse effects vary between drugs but include arrhythmias, heart block and QT prolong
There are two main types of neuromuscular blockers: competitive antagonists like curare and depolarizing blockers like succinylcholine. Competitive antagonists work by competitively binding to nicotinic receptors at the neuromuscular junction, while depolarizing blockers cause sustained depolarization of the end plate. Neuromuscular blockers differ in their mechanism of action, duration and speed of onset/offset, selectivity, and side effect profiles. Common examples include succinylcholine, atracurium, pancuronium and vecuronium.
Narcotics and Non-Narcotics Analgesics.pptxFarazaJaved
This document summarizes narcotic and non-narcotic analgesics. It describes major classes of analgesics including opioids, NSAIDs, acetaminophen, flupirtine, and ziconotide. Specific drugs are discussed including morphine, methadone, fentanyl, codeine, tramadol, acetaminophen, NSAIDs, flupirtine and ziconotide. Their mechanisms of action, uses, adverse effects, and classification as pure agonists, partial agonists, antagonists are summarized.
Hyperlipidemia is a common disorder caused by abnormalities in lipid metabolism or transport. It results in high levels of lipids like cholesterol and triglycerides in the blood. Hyperlipidemia is classified based on the abnormal lipid levels and is primarily treated through lifestyle changes and medications that lower lipid levels. Common drug classes used to treat hyperlipidemia work by inhibiting cholesterol synthesis, breaking down fats, or blocking lipid absorption.
Drugs acting on Renin Angiotensin Aldosterone system Dr Htet
This document discusses drugs that act on the renin-angiotensin-aldosterone system (RAA system). It describes the RAA system and lists the main drug classes: renin inhibitors, ACE inhibitors, angiotensin receptor blockers, and aldosterone antagonists. For each drug class, it covers the mechanism of action, pharmacological effects, clinical uses, and adverse effects. The key drugs discussed are aliskiren, various ACE inhibitors like enalapril and lisinopril, angiotensin receptor blockers like losartan and valsartan, and aldosterone antagonists spironolactone and eplerenone.
Sulfonylureas are oral hypoglycemic drugs that enhance insulin secretion from the pancreas. They work by blocking ATP-sensitive potassium channels in pancreatic beta cells, which leads to insulin release. Common side effects include hypoglycemia and weight gain. Examples include glibenclamide, glipizide, and glimepiride. Choice of sulfonylurea depends on factors like duration of action, renal function, and patient age. They are generally effective treatments for type 2 diabetes but require caution in elderly patients or those with kidney/liver problems.
This document discusses angiotensin receptor blockers (ARBs) which are used to treat hypertension and other cardiovascular conditions. It notes that ARBs work by competitively blocking the angiotensin receptor type 1, leading to vasodilation and other effects. Some examples of individual ARB drugs are provided like losartan, candesartan, and valsartan. The document compares ARBs to ACE inhibitors, noting that ARBs do not cause cough like ACE inhibitors. It concludes by discussing the theoretical rationale and benefits of combining ARBs with ACE inhibitors to more completely suppress the renin-angiotensin system.
PPt on Opioid Analgesics for paramedical students (BPT/BSc Nursing)Dhruva Sharma
- Morphine is the prototypical opioid analgesic extracted from the opium poppy. It acts primarily on mu-opioid receptors in the central nervous system to produce analgesia.
- Morphine administration results in pain relief, sedation, respiratory depression, constipation, and a risk of tolerance and physical dependence developing with chronic use.
- While morphine remains a gold standard for pain treatment, its use requires precautions around side effects like respiratory depression, especially in high-risk groups such as infants, the elderly, and those with respiratory conditions.
Histamine and bradykinin are important autacoids or local hormones that act near their site of synthesis to exert physiological effects. Histamine is released from mast cells and basophils during allergic reactions and binds to H1, H2, H3 and H4 receptors, causing effects like vasodilation, increased vascular permeability, and bronchioconstriction. It is involved in allergic diseases. Bradykinin is produced from kininogen and acts on B1 and B2 receptors to cause vasodilation, smooth muscle contraction, increased vascular permeability and pain. Both histamine and bradykinin are inactivated by enzymatic degradation and their effects can be blocked by receptor antagonists.
This document discusses antiarrhythmic drugs used to treat irregular heart rhythms or arrhythmias. It describes the mechanisms that can cause arrhythmias such as enhanced pacemaker activity, after-depolarizations, and reentry. It then covers the major classes of antiarrhythmic drugs including class I sodium channel blockers, class II beta blockers, class III potassium channel blockers, and class IV calcium channel blockers. Specific drugs from each class are discussed, how they work, their therapeutic uses, and potential side effects. Common arrhythmias like atrial fibrillation, atrial flutter, and ventricular tachycardia are also defined.
Pharmacotherapy of Chronic Obstructive Pulmonary DiseaseTsegaye Melaku
A 58-year-old man with COPD and hypertension is admitted to the hospital for an exacerbation of his COPD. He is treated with oxygen, bronchodilators, corticosteroids, and antibiotics. The goals of COPD treatment are to reduce symptoms, improve quality of life and exercise tolerance, and prevent exacerbations and hospitalizations through pharmacologic and non-pharmacologic therapies like smoking cessation, vaccination, pulmonary rehabilitation, and in severe cases, long-term oxygen therapy or surgery. Proper diagnosis involves assessing symptoms, risk factors, and using spirometry to confirm persistent airflow limitation.
General Anaesthesia produces reversible loss of sensation and consciousness through the use of drugs. There are two main classifications of anaesthetics - inhalational and intravenous. Inhalational includes gases like nitrous oxide and liquid anaesthetics administered using a vaporizer. Intravenous anaesthetics include inducing agents like thiopentone sodium and propofol, as well as slower acting drugs like ketamine and benzodiazepines. Anaesthesia involves three stages - induction, maintenance, and recovery. The ideal stage for surgery is stage III, where there is loss of muscle tone and reflexes. Careful monitoring is needed to prevent progression to stage IV, which can cause respiratory and circulatory depression.
Phenytoin is an anti-seizure medication that works by blocking voltage-gated sodium channels in neurons. It has nonlinear pharmacokinetics and a narrow therapeutic index. Common side effects include gingival hyperplasia and nystagmus. Serious potential side effects include bone marrow suppression, low blood pressure, and Stevens-Johnson syndrome. It must be carefully monitored due to risks of toxicity at high doses.
Barbiturates are derivatives of barbituric acid that act as central nervous system depressants. They have multiple mechanisms of action in the brain involving GABA receptors and ion channels. Barbiturates are classified based on their duration of action and include long, intermediate, short, and ultrashort-acting varieties. While once widely used as sedatives, hypnotics, and for anesthesia, barbiturates have significant disadvantages like low therapeutic index, drug interactions, abuse potential, and severe withdrawal syndrome. Newer agents like benzodiazepines, buspirone, zolpidem, and zaleplon have replaced barbiturates for most indications due to safer profiles
This presentation was given by me during my M.pharm.
It contains description, classification, mechanism of actions and therapeutic uses of Neuromuscular blockers.
Local anesthetics reversibly depress the central nervous system to relieve pain without loss of consciousness. They work by binding to voltage-gated sodium channels in nerve cell membranes, inhibiting the generation of action potentials and reducing nerve excitability. Local anesthetics are classified as amides or esters depending on their chemical structure. Amides are more stable but esters have a faster onset of action. Both types contain an aromatic ring connected by an amide or ester linkage to a hydrophilic amine group, allowing them to penetrate cell membranes. The presence of electron-withdrawing groups on the aromatic ring and lipophilic chains influence their potency and duration. Common applications of local anesthetics include dentistry, dermat
This document summarizes the presentation of a research article on the development and validation of an RP-HPLC method for the simultaneous determination of metformin and evogliptin in pharmaceutical formulations. The method was developed using a C18 column with an isocratic mobile phase of methanol and water at pH 3. Both drugs showed good separation and were detected at 254 nm. The method was validated and found to be linear, precise, accurate, robust, and specific for quantifying the drugs in tablets within 3 minutes. The method can be applied for routine quality control analysis of metformin and evogliptin combinations.
1) The co-op student worked at Bristol-Myers Squibb to optimize protein purification chromatography conditions and improve impurity clearance.
2) High-throughput screening was used to evaluate different buffer and resin combinations. Process conditions were optimized to separate variants and improve purity.
3) The student met project goals including developing chromatography methods, characterizing protein populations, and providing insights into improving processes. The work focused on optimizing the initial protein A capture step to reduce downstream purification needs.
Quantitative and Qualitative analysis of Toxicology pharm 402Justas Lauzadis
The document discusses quantitative and qualitative analysis of toxicology compounds. In the qualitative analysis, four compounds were extracted from rabbit serum at different pH levels using liquid-liquid extraction and GC/MS. Two compounds were extracted at basic pH and one at acidic pH, while one compound was not extracted. In the quantitative analysis, reverse phase HPLC was used to analyze malathion concentrations in water samples. Calibration curves were made using standards and an internal standard. The sample analysis found a higher concentration than expected due to loss of product, which was corrected using the internal standard data. Improper pipetting was identified as the source of error.
The document summarizes research into developing tamoxifen citrate-loaded nanoparticles using the biodegradable polymer PLGA for breast cancer treatment. PLGA nanoparticles containing tamoxifen citrate were prepared using emulsion solvent evaporation techniques. Process parameters like drug-polymer ratio and homogenization speed were optimized. Characterization studies showed the nanoparticles were spherical and smooth. In vitro drug release was evaluated over time, with release profiles varying by centrifugation speed. Drug loading efficiency ranged from 18.6-71.98%. The nanoparticles showed potential as a controlled drug delivery system for tamoxifen citrate.
The document discusses applications of liquid chromatography-mass spectrometry (LCMS). It describes how LCMS combines liquid chromatography separation with mass spectrometry detection. Several studies using LCMS are summarized, including analyzing phytochemicals in Solanum plants and identifying compounds in Archidendron bubalinum seed shell extracts. Key components detected include chlorogenic acids, flavonoids, alkaloids, and the compounds phlorizin and astilbin.
This lab report summarizes the results of indirect calorimetry tests performed on two subjects to determine their resting metabolic rate and substrate utilization. The first subject was a female weighing 58.18 kg and the second was a male weighing 76.36 kg. Unexpectedly, the results showed the first subject had a higher RMR of 1786 kcal/day compared to 1579 kcal/day for the second subject. The substrate utilization also differed from expected values at rest. Several possible factors are discussed to explain the discrepancies between the subjects and expected results, including differences in testing conditions and human error.
Haemolysis effect of Mefenamic Acid 250 mg Capsule in Bio analysis by liquid ...IOSR Journals
A rapid, simple and specific method for estimation of Mefenamic acid in human plasma was validated using Indomethacin as internal standard. The analyte and internal standard were extracted from plasma using simple solid phase extraction. The compound were separated on a reverse-phase column with an isocratic mobile phase consisting of 2 mM Ammonium Acetate in Water and acetonitrile (20:80, v/v) and detected by tandem mass spectrometry in negative ion mode. The ion transition recorded in multiple reaction monitoring mode were m/z 240.1 196.0 for Mefenamic acid and m/z 356.1312.0 for internal standard. Linearity in plasma was observed over the concentration range 35.000 – 7000.000 ng/mL for Mefenamic acid. The cv of the assay was 4.89 % to 5.98 % and accuracy was 99.36 to 102.20 % Intra and Interday respectively at LLOQ level. The validated method was applied to bioequivalence study of 250 mg Mefenamic acid in 28 healthy human volunteers. Total 50 samples from individual volunteers identified as Haemolyzed which were analyze initial and repeat again to cross check the method reproducibity for Haeamolysis effect and compared which found acceptable range
This document describes the development and validation of a new reverse phase high performance liquid chromatography (RP-HPLC) method for the estimation of paracetamol in pharmaceutical dosage forms. Some key points:
- An isocratic RP-HPLC method was developed using a mobile phase of acetonitrile and potassium dihydrogen orthophosphate buffer at a ratio of 15:85, pH 2.5.
- The method was validated for parameters such as linearity, accuracy, precision, limit of detection, limit of quantification, and robustness as per ICH guidelines.
- The method showed good linearity in the range of 25-60 μg/ml with a correlation coefficient of 0.999
Nilesh Dashrath Kamble presented a seminar on method development and validation in HPLC. The presentation discussed the steps involved in HPLC method development including column selection, mobile phase composition, pH range selection, and optimization of separation conditions. It also covered validation parameters such as accuracy, precision, specificity, limit of detection, and limit of quantification as per ICH guidelines. The presentation included an example method development for the simultaneous estimation of atorvastatin and telmisartan from a tablet formulation.
Modern and effective methods in the development of natural productsTejasSonawane19
The file is all about the modern and effective method for the development of natural products . and to explore the traditional system globally . the one who wants to make his product effective and stable he must follow these methods .
This document discusses chromatography and PCR techniques. It provides details on:
- The principles and types of chromatography including TLC, HPLC, and their components and procedures. HPLC allows for quantitative analysis and is commonly used for pharmaceutical quality control.
- PCR amplification which uses DNA polymerase to exponentially replicate DNA sequences. It requires template DNA, primers, nucleotides, and DNA polymerase. Repeated heating and cooling cycles allow for target DNA replication.
- Applications of chromatography and PCR include pharmaceutical analysis, forensic analysis, detection of genetic disorders, microbial detection, and molecular biology research techniques. Both provide powerful tools for separation, detection, and analysis of biological molecules.
This document summarizes an experiment that used UV-vis spectrophotometry and HPLC to analyze and compare the caffeine concentrations in various caffeinated and decaffeinated beverages. The experiment extracted caffeine from samples using dichloromethane, then quantified the caffeine concentrations using Beer's Law analysis of UV-vis absorption spectra and retention times from HPLC chromatography. The results observed differences between reported concentrations and experimental data, and found that some decaffeinated beverages contained caffeine exceeding FDA limits to be considered decaffeinated.
This document summarizes the presentation of a new RP-HPLC method for the simultaneous determination of metformin and evogliptin in bulk and pharmaceutical dosage forms. The method utilizes a Waters XTerra RP-18 column with a mobile phase of acetonitrile, potassium dihydrogen phosphate, and methanol. Metformin and evogliptin were well separated with retention times of 2.73 and 4.47 minutes, respectively. The method was validated per ICH guidelines and showed good linearity, accuracy, precision, specificity, robustness and sensitivity. Forced degradation studies indicated the method can separate metformin and evogliptin peaks in the presence of degradation products.
This document describes the development and validation of a reverse phase HPLC method for the simultaneous estimation of metformin and linagliptin in pure form and pharmaceutical formulations. The method utilizes a C18 column, mobile phase of phosphate buffer and acetonitrile (60:40) at a flow rate of 1 mL/min. Metformin and linagliptin were well separated with retention times of 3.048 and 4.457 minutes respectively. The method was validated per ICH guidelines and showed good linearity, accuracy, precision and recovery for both drugs. The method can be used to simultaneously quantify metformin and linagliptin in tablet formulations.
The document discusses preparative high performance liquid chromatography (prep HPLC). It begins with an introduction to prep HPLC, noting it was developed in the 1970s to increase throughput and separation power compared to analytical HPLC. The principles, instrumentation, and differences between analytical and prep HPLC are then described. Various hyphenation techniques for prep HPLC including with mass spectrometry and flash chromatography are also covered. Finally, applications of prep HPLC like purification and an example study using it to purify saffron metabolites are summarized.
This document describes the development and validation of a reverse phase HPLC method for the analysis of lamotrigine. Lamotrigine was separated using a C18 column with a mobile phase of acetonitrile and water (50:50) at a flow rate of 1.5 mL/min. Validation of the method included evaluation of linearity, robustness, precision, limits of detection and quantification, and analysis of lamotrigine tablets. The method was found to be linear over a concentration range of 7-31 μg/mL. Robustness and precision tests met acceptance criteria. The limits of detection and quantification were 0.07 μg/mL and 0.23 μg/mL respectively. Analysis of lam
1. The Determination of Methylxanthines in Cocoa, Coffee
and Tea using HPLC
FACULTY OF APPLIED SCIENCE
LIMERICK INSTITUE OF TECHNOLOGY
MOYLISH PARK
LIMERICK.
Bachelor of Science (Honours) in Chemical Instrumentation & Analysis
(Level 8)
Submitted by: Iqimat Oloko
Supervisor: Dr. Michael Monaghan
2. DECLARATION
I certify that this thesis which I now submit for my project for the part of my final year in
Chemical Instrumentation and Analysis , is entirely my own work and has not been taken from
the work of others, save and to the extent that such work has been cited and acknowledged
within the text of my work.
This thesis was prepared according to the regulations provided by Applied Science Department
The Institute has permission to keep, lend or copy this thesis in whole or in part, on condition
that any such use of the material of the thesis is duly acknowledged.
3. Acknowledgements.
I would like to thank Dr. Michael Monaghan for his help and knowledge in
delivered to this project. I would like to thank all the LIT technicians for all their
support over the laboratory period.
4. Abstract
The determination of Methylxanthines (Caffeine, Theobromine and Theophylline) was
analysed using HPLC. The standards were used as a calibration curve to quantify the samples
carried out. The samples carried out are Cocoa, Coffee and Tea bags.
Methods were developed for the analysing of methylxanthine and was validated. SPE
extraction Pre-treatment was utilised on the sample and it was characterised using HPLC.
Another method were developed in determining the caffeine in sample by GC- Mass
spectrometry
The HPLC was used to analysed amount of methylxanthine are in each samples which result
to that Theobromine is mainly made from Cocoa observing from the HPLC chromatogram. It
was also observed that the Coffee has a lot of Caffeine which is about 1.2g of caffeine in
Richman Blend Coffee. Theophylline was hardly found in the three samples, just a little bit of
trace of theophylline.
5. Abbreviations
HPLC- High Pressure liquid Chromatography
RP- HPLC- Reversed Phase –High Pressure liquid Chromatography
GC-MASS spectrometry – Gas Chromatography –Mass Spectrometry
SPE- Solid Phase Extraction
FDA- Food and Drug Administration
6. Aims and Objective
The main aims is to determine the amount of methylxanthine in Cocoa powder, Coffee and Tea
using HPLC.
What are the objective to achieve in this project?
The first objective to achieve is
1. Method validation
Method development has to be validated in purpose of the analysis of methylxanthines. The
method development has to go under what type of mobile phase, flow rate and column to use.
2. How to extract the samples
The steps of SPE extraction of methylxanthine from samples has to well understand if reversed
phase or normal phase will be use.
3. Optimization of separation
The method validated has to sure it can separating the three components of methyxlanthine
with good theoretical plate number, resolution factor and tailing factor.
4. Quantitative
To quantify the amount of caffeine, theobromine and theophylline in each samples.
5. Using another method to qualify methylxanthine
To use GC-Mass spectrometry to identify the methylxanthine and observe if the fragment of
the three methylxanthine will be known.
7.
8. Table of Contents
1 Introduction ..................................................................................................................................11
Coffee....................................................................................................................................11
Tea.........................................................................................................................................12
Cocoa.....................................................................................................................................13
Methylxanthine Chemistry and general Information ...........................................................14
1.4.1 The physiochemical properties.....................................................................................16
Clinical Use of Methyxlanthine .............................................................................................17
1.5.1 Methylxanthine and CNS stimulation ...........................................................................17
1.5.2 Methyxanthine and Diuretic.........................................................................................18
1.5.3 Methyxlanthines and Smooth muscles.........................................................................18
World Consumption of Caffeine ...........................................................................................19
1.6.1 Caffeine Content in Beverages......................................................................................19
1.6.2 Theobromine content in Cocoa ....................................................................................19
SPE Apparatus.......................................................................................................................20
High Pressure liquid Chromatography..................................................................................21
1.8.1 HPLC Instrumentation...................................................................................................21
HPLC Methods Development................................................................................................23
Gas Chromatography -Mass spectrometry...........................................................................25
Methods of Analysis Methylxanthines in food .....................................................................26
2 METHOD........................................................................................................................................29
Materials ...............................................................................................................................30
Preparation of mobile phase ................................................................................................30
Preparation of Caffeine.........................................................................................................30
Preparation of Theobromine ................................................................................................30
Sample Preparation ..............................................................................................................30
Instrument ............................................................................................................................31
2.6.1 HPLC ..............................................................................................................................31
2.6.2 GC-Mass spectrometry .................................................................................................31
3 Method Validation........................................................................................................................32
Validation of the Chromatographic Method ........................................................................33
3.1.1 Linearity and Range.......................................................................................................33
9. 3.1.2 Precision – percentage RSD value.................................................................................34
3.1.3 Accuracy........................................................................................................................34
3.1.4 Limit of Detection .........................................................................................................36
3.1.5 Limit of Quantification ..................................................................................................37
3.1.6 Specificity......................................................................................................................38
4 Discussion......................................................................................................................................39
Method development and validation of Caffeine.................................................................40
Sample...................................................................................................................................46
Gas Chromatography ............................................................................................................48
5 Conclusion.....................................................................................................................................51
6 Future work...................................................................................................................................51
7 Calculations...................................................................................................................................52
Theobromine.........................................................................................................................52
Theophylline..........................................................................................................................57
Caffeine.................................................................................................................................59
8 References ....................................................................................................................................65
9 Appendices....................................................................................................................................68
10.
11. 1 Introduction
Coffee
Methylxanthines;caffeine(1,3,7-trimethyxanthine),theobromine(3,7-dimethylxanthine),and
theophylline(1,3-dimethylxanthine) can be normally found in coffee beans, tea leaves, cocoa
beans and any other kinds of the plant for drugs (Paradkar, M.M, and Irudayaraj, 2002). The
historical origins of the use of methylxanthine are unknown and dressed in myth. Coffee, tea
are the most recent common use. Coffee became widespread in the fifteenth and sixteenth
centuries and in Europe it occurred in the eighteenth and nineteenth centuries. The word Coffee
derived from qahva which means denoting a drink from plants. From the initial cultures of
Ethiopia, cultivation of coffee bushes soon came to be dominated by Yemen, the city became
a centre to denote drink. Venetian traders introduced coffee to Europe. In London, the first
coffee shop opened in 1652 and was located in St. Michael’s Alley, Cornwall. (B.Fredholm,
2011, p. 3) Coffee drinking has been introduced into France nine years earlier and by 1690,
250 coffee houses were registered in France; by 1782, the number had risen to 1800. Now
coffee is grown in 50 different countries around the world. (B.Fredholm, 2011, p. 4)
.
Figure 1: showing an Arabica coffee see (vine, 2015)
12. Tea
Tea became popular use during the Ming Dynasty in China and during the eighteenth century
in Britain. Tea use increased in popularity under the Chinese Ming Dynasty (1368-1644),
which represented a return to power of the Han People, it was at this period tea began to be
brewed by steeping cured loose leaves in boiling water, and this was tried by Europeans, it was
this method of making tea that became popular in the world (B.Fredholm, 2011, p. 6). Tea
arrived in Europe about the same time as Coffee. The first green tea leaves were brought from
China to Amsterdam by the Dutch East India Company by 1636. From its early history, Tea
has become one of the world's ubiquitous drinks. Tea drinking in one form or another is part
of the diverse cultures of many lands. Recent years have seen considerable interest in tea’s
therapeutically properties, which is one of the factors leading to an increase in tea consumption.
It was esteemed for its ability to dispel tiredness, to stimulate the mind and to raise energy
levels, even helps to banish fevers and cure head and stomach problem. (Saberi, 2010).
Figure 2 : showing a Tea leaves (Camellia sinensis) from Köhler's Medicinal Plants, 1897 (WikiTea, 2016)
13. Cocoa
The cocoa tree belongs to the genus Theobroma cacao tree, a group of small trees which occurs
in the wild in the Amazon basin and other tropical areas of south and Central America. Over
different species in the genus but a cocoa tree is only cultivated widely. The tree forms flowers
from small cushions on its trunk and large branches. The flowers polluted produced pods that
vary from 100 to 350mm in length and width. In 1502, cocoa seeds were bought by Columbus
to King Ferdinand on his fourth and final voyage (Tannenbanum, 1941). The first plant
products containing methylxanthines. The Spaniards promptly discovered the great value of
cocoa, which is highly used beverages and currency. The first documented arrival of cocoa in
Spain was 1544 and first official shipment reached Seville from Veracruz (Tannenbanum,
1941). Cocoa contains the amines and alkaloids theobromine about 0.5% to2.7%, caffeine
approximately 0.25% in cocoa. A standard chocolate bar (40 to 50g) contains theobromine (86
to 240mg) and caffeine (9 to 31mg). The characteristic bitter taste of cocoa is generated by the
reaction of diketopiperazines with theobromine during roasting. Theobromine is produced
commercially from cocoa husks (Health, 2009).
Figure 3: showing a tree of Cocoa in Papu Vaai in Asau and Saena Penaia’s plantation at Lafi (Tavita, 2012)
14. Methylxanthine Chemistry and general Information
Methylxanthines are secondary plant metabolites which are derived from purine compounds
nucleoids. These purine base are found in human body, tissues and organism. The types of
methylanthien are Caffeine(1,3,7-trimethylxanthine),Theophylline(1,3-dimethylxanthines)
and Theobromine(3,7-dimethylxanthine), these are found in tea, coffee and cocoa.
Caffeine Theophylline Theobromine
Figure 4: Showing the structure of methylxanthines
Physical and chemical properties of Methylxanthines
Properties Caffeine Theophylline Theobromine
Molecular Formula C8H10N4O2 C7H8N4O2 C8H10N4O2
Molecular Weight 194.19g/mol 180.16 180.16
Melting Point 235-238 271-273 357°C
Log P -0.55 -0.77 -0.78
pKa 10.4 8.81 9.28
Water Solubility 11.0mg/mL 9.74mg/mL
Boiling Point 178 454 357
Table 1:showing the physical properties of methylxanthines (Group, 2007)
CH3
H3C
CH3
CH3
H3C
H
CH3
CH3
15. Caffeine is a chemical compound which occurs naturally from plant sources. Caffeine belong
to family of heterocyclic groups of compounds which are called purines.Caffiene
IUPAC(International Units of Pure and Applied Chemistry) name is 3,7-dihydro-1,3,7-
trimethyl-1H-purine-2,6-dione and it has a common name called 3,7-trimethylxanthines. From
the structure in figure 4, caffeine is classified as alkaloids since it occurs as a metabolism of
nitrogen metabolism. (Group, 2007)
Theobromine is an alkaloid generally found in cocoa beans and hence chocolate. It is the least
active as a central nervous stimulant of the three naturally occurring methylxanthines.
Theobromine IUPAC (International Units of Pure and Applied Chemistry) name is 3, 7-
Dimethyl-3, 7-dihydro-1H-purine-2,6-dione and has a common name called 3, 7-
dimethylxanthine. Theobromine is white in colour and slightly soluble in water. Theobromine
has weakly acidic properties, combining with bases to forms salts. Theobromine also has even
weaker basic properties, combining with acids to form salts which are decomposed in aqueous
solution. (Group, 2007)
Theophylline is an alkaloid found in plants such as the leaves of the tea brush. It is primarily
used as a drug for the treatment of asthma. The major pharmacological actions of theophylline
include stimulation of the cardiac muscle causing a complete emptying of the heart; relaxation
of the bronchial muscle; acting as a diuretic increasing urine output and stimulation of the
central nervous system. (Group, 2007)
16. 1.4.1 The physiochemical properties
How can structure properties of compounds be described?
Lipinski rules are the guidelines for structural properties of drug like compounds. These rules
are used to describe the physiochemical properties of compounds.
The most common five rules set for the physiochemical properties of compounds are:
1. Not more than 5 hydrogen bond donors
2. Not more than 10 hydrogen bond acceptors
3. A molecular weight under 500g/mol
4. The partition coefficient lop P less than 5
Lipophilicity is the ability of a compound to dissolve in fats, oils, lipids and non –polar solvent.
It is also to partition the compound between immiscible non-polar and polar liquid phase. The
partitioned values are measured and termed ad Log P and Log D.
Log P is the partition coefficient of the compound between an organic phases an aqueous phase
at a pH whole all the compound molecules are in neutral form.
Log D is the distribution coefficient of the compound between an organic phase and aqueous
phase at a specified pH.
How does Log P affect Reversed Phase HPLC?
Reversed phase HPLC is the instrument used in when a mobile phase is polar and the stationary
phase is non-polar. The instrument will be explained better in this section.
This RP-HPLC will be used to explain how to separate ionisable compounds. In this process,
the higher the log P, the more hydrophobic the molecule. In RP-HPLC polar analyte interact
with silica surface silanol groups which undergo an adsorption type interaction with their
partitioning behaviour. This lead to bad peak shape along with increasing in retention times.
The structure of the standard molecule gives clues to their elution order and this is based on
the water solubility of the molecule. (Scientific, n.d.)
There are some observations governing the compounds elution. Which are:
1. The less water soluble, the more the retention
2. The retention time increases as the number of atoms increase
3. Branched-chain compounds elute more rapidly than normal isomers
4. Unsaturation decreases retention
5. Neutral polar and charged species shows the least retention time followed by the acid
then basic compounds elute rapidly. (Scientific, n.d.)
17. Clinical Use of Methyxlanthine
Methylxanthine have four most common pharmacological actions which are;
CNS stimulation
Diuresis
Stimulation of Cardiac muscle
Relaxation of smooth muscle; especially the bronchial muscle. (Rang, Dale, Ritter, &
Flower, 2004)
1.5.1 Methylxanthine and CNS stimulation
Of the methyxlamthine, caffeine is the most effective used to improve mental alertness. This
is usually achieved by blocking adenosine receptors in the brain. Adenosine signals the brain
that it is time for the body to sleep. Caffeine increases energy metabolism throughout the brain.
This stimulating effect of increased alertness can lead to Insomnia. The caffeine contained in
beverages 100mg in a cup is sufficient to cause nervousness and insomnia in sensitive
individual. (Rang, Dale, Ritter, & Flower, 2004) A very high dose of caffeine can cause
medullary stimulation and convulsions and may lead to death. Generally, caffeine has a
stimulant can be used as a potent killer; caffeine has found relevance in the preparation of pain-
relieving drugs especially for headache originating from eye strain by exerting a peripheral
action which is the site of an injury, this acts on muscles tissue by repairing tissue damage and
also reducing the inflammation. (Bennett Alan Weinberg and Bonnie K. Bealer, 2016)
( Clark & Landolt, 2015) designed a study associated with caffeine, coffee and sleep. The
method was conducted using a computerised literature search on web of science. The surveys
associated caffeine with variable of sleep quality in adolescent are estimated that 30% of
America adolescents consume caffeinated beverages on daily basis, soda(drinks) appears to be
the beverages of choice. Data from a nationally representative survey with 15,686 respondents
revealed that more than two-thirds drank soda once a day or more. Respondents drank coffee
less frequently, with over one half not drinking coffee at all and two thirds drinking it once a
week or less. Adolescents reporting high caffeine intake (consumption n=4,243) were 1.9times
likely to experience difficultly in sleeping and 1.8 times more likely to experience sleepiness
in the morning compared to adolescent with low caffeine, beside with shortness of sleep,
daytime sleepiness has been associated with high a moderate caffeine intake aiming adolescent.
( Clark & Landolt, 2015)
18. 1.5.2 Methyxanthine and Diuretic
Theobromine has diuretic, stimulant properties, but unlike caffeine theobromine does not affect
the central nervous system. Diuretics work by causing the kidney to excrete increased amounts
of salts and water from the body. (Ruben Vardanyan, 2016). Diuretics is mostly common in
sports, which has been banned by most sports organizations because the athletes intend to cheat
in sports by excreting all the doping used for performance and most especially diuretics make
athletes lose water wright quickly (Ruben Vardanyan, 2016).
1.5.3 Methyxlanthines and Smooth muscles
Methylxanthines act as bronchodilators by relaxing
bronchial smooth muscle and help to narrow the
airways. Theophylline and Theobromine are the
primarily used for therapeutic drug for this process.
(Rang, et al., 2004)
Figure 5 :A diagram of the bronchus. The loosening of the muscles in the bronchus caused by theobromine helps alleviate
the symptoms of asthma. (Henry Vandyke Carter, 1918)
19. World Consumption of Caffeine
How much does the world take beverages daily?
Caffeine is used daily by millions of people to increase wakefulness, reduce fatigue and improve focus.
Up to 400 milligrams of caffeine appears to be safe for healthy adults. (Books, 2016)
Caffeine is present in number 0f dietary sources consumed worldwide for example tea, coffee, cocoa
beverages, bars, soft drinks.
Age Range Maximum recommended daily caffeine intake
4-6 45mg
7-9 62.5mg
10-12 85mg
Adult Up to 400mg
Table 2 showing the maximum intake of caffeine recommend in beverages (Books, 2016)
1.6.1 Caffeine Content in Beverages
Product Serving Size Caffeine per
serving(mg)
Caffeine mg/L
Cocoa Powder 1 bar(43g) 31 -
Milk Chocolate 1 bar(43g) 10 -
Coffee powder 207mL 80-135 386-652
Tea for 3 min 177 millilitres 22-74 124-418
Table 3 showing the caffeine content in beverages (Books, 2016)
1.6.2 Theobromine content in Cocoa
Cocoa types Mean theobromine content ratio(10-3
)
Cocoa 20.3
Cocoa cereals 0.695
Chocolate products 1.47
Cocoa beverages 2.66
Table 4 showing the amount of theobromine in cocoa.
20. SPE Apparatus
Solid phase extraction (SPE) involves running samples through a suitable sorbent bed. This
stationary phase is normally a silica based
sorbent which the functional groups are
bonded to. The sorbent is contained within a
polypropylene disposable syringe. The syringe
contains a packing material of sorbent ranging
from 100mg-5g that is held in place by
polyethylene frits. At the tip of the syringe is
called a leur tip which allow for ease fitting
onto the equipment (SPE manifold vacuum.)
The polypropylene syringes are available in
different sizes (1-10ml) capacities. (cutris,
2016)
Figure 6 showing Varian Vacuum SPE Manifold with Vacuum
pump,HyperSepTM VerifyTM-CX, HyperSepTMPhenyl and HyperSepTMPhenyl and HyperSepTMC18SPE Cartridges (E. M. Thurman,
2016)
The SPE Process generally consists of four stages which are:
Step 1. Wetting/Conditioning: First Methanol then followed by water (reversed phase).
Wetting the sorbent allows the boned alkyl chains, which are twisted and collapsed on
the surface of the silica to be solvated so that they ‘spread open’ to form a ‘bristle’.
Ensures good contact between the compound and the sorbent in the adsorption stage.
Step 2: Loading aqueous sample (Revered Phase)
Sample is forced through the sorbent material by suction.
With the choice of the sorbent, the compound of interest will be retained by the sorbent
in preference to extraneous material.
Step 3: Washing –interference elution
This is the most important stage.
Wash off unwanted materials using the same solution in which the sample was
dissolved, or another solution that will not remove the desired compound.
Step 4:
Analyte elution and collect the elute
.
21. High Pressure liquid Chromatography
High pressure liquid chromatography (HPLC) is one technique widely used in an analytical
laboratory. HPLC is based on the analysis of organic molecules and ions with their
involvement of adsorption, partition and ion exchange, depending on the type of stationary
phase used. HPLC contains a solid stationary phase, normally packed stainless- steel 3-4mm
bore and 10-30cm long column, and a liquid mobile phase (P.J.Higson, 2004). The two basic
important question in HPLC focus on how particular compounds can be separated and why
particular compounds were separated by HPLC method. Separations of the component of a
solution results from the difference in the relative distribution ratio of the solutes between the
two phases. HPLC can be used as qualification and quantification analysis; these can determine
the purity and the content of many pharmaceutical substances. HPLC operates in two phases;
Reverse phase chromatography and normal phase. Reverse phase chromatography is usually
the most common process to use. A non- polar stationary phase and polar mobile phase was
used. The solvent for mobile phase for this chromatography is mixture of water and methanol
or acetonitrile. In normal phase chromatography the stationary phase is usually polar in nature
(silica gel) and the mobile phase is non polar (hexane) (Shu, Chem, n.d.). In order to maximize
the result or sensitive results, the analyte are usually dissolved with the mobile phase. The
mobile phase allows the efficient separation within a minimum of time.
1.8.1 HPLC Instrumentation
HPLC components are shown on the diagram below in figure 1. The different component of
HPLC are Injection, HPLC Column, Mobile phase, Pump and Detector. How does these
component works on HPLC? The solvent is the mobile phase. The mobile phase acts as a
transportation of sample into the system. The mobile phase are inertness onto the sample. For
normally phase the mobile phase are usually non-polar (hexane) and for reversed phase the
mobile are usually polar (water: methanol or acterntile). The mobile phase has to be free from
impurities. The pump (Eluent Delivery system) is the most important component of HPLC
which is used to generate pressure with a specific flow rate of the mobile phase. Variations of
flow rate of the mobile phase has impact on the elution time of the sample. For quantification,
a precise flow rate improves the reproducibility of gradient elution on a standard size columns
of stationary phase. Injectors supply a constant volume injection of sample into the mobile
phase and transport the sample into the HPLC column. HPLC column is packing material called
stationary phase. The stationary phase enhance the separation of the sample after run. A
detector gives precise response for the sample separated.
22. The most common detector use is Photodide array detector. Phototodide array detector provide
a fast low noise spectra; analysis, resolution determined by number of diodes deployed over
specific wavelength
range.
Figure 7 showing the
diagram of photo diode
array detector from
(Scientific, 2013)
HPLC photo diode
array is coupled to
the column to elute out the separation component by molecular weight, hydrophobicity
(reverse-phase) or ionic charge. This makes it very important for HPLC analysis. Specific
PDA detectors usually handle the over all of the spectrum from the UV at 190nm to near IR at
1micron where some others PDA detectors target to the UV, visual or near IR with up to 2048
elements provided for ultimate flexibility in resolution. These type of machine provide
sampling speeds of up 190Hz and provide thermoelectric temperature to minimize the noise
limit. (Labcompare, 2009). The mobile phase leaves the detector and later sent to the waste
reservoir. (Waters, 2006 )
Figure 8(a,b) : showing the diagram of HPLC from Waters technology (Waters, 2006 )and b from Limerick Institute of
Technology analytical Laboratory
23. HPLC Methods Development
Carrying out quantitative analysis in any set of samples, it is very important to develop a
specific preparation and separation. In developing a method for separation, problem must be
identified, and the most problem are based on the physicochemical property of the standard
compounds and the methods available for the separations. Chromatographic method
development and system suitability are the problems for separation. According to FDA,
analytical method validation characteristics is the new methodology to justify the acceptance
criteria, using a qualified instrumentation. The typical Validation characteristic are:
Specificity: The ability of a test method to measure an analyte without interference from
other sample.
Linearity: The measure of a test methods ability to obtain test results directly
proportional to the concentration of analyte in the sample. The acceptance criteria for
linearity is < 0.99
Precision: The agreement of two or more measurement that are obtained under identical
condition using the same test method.
Accuracy: The agreement between a measured value and accepted value
Limit of Detection: The lowest concentration of analyte in a sample matrix that is
detected.
Limit of Quantitation: The smallest amount of analyte in a sample matrix that can be
quantified with acceptable accuracy and precision.
Range: Range is the magnitude for the analytical concentration where the precision,
accuracy and linearity all meet acceptable criteria.
System suitability tests are fundamental part of liquid chromatographic methods. They
confirmatory tests procedures carried out to ensure that the system will function correctly for
the intended use. The chromatographic test used to describe the performance of the column,
system and the separation are (Greay, 2016)
24. The Capacity Factor
Capacity factor is a measurement of retention of an analyte of a chromatographic column.
K =
𝑡𝑅−𝑡𝑂
𝑡𝑂
tR is the retention time; time required for the peak
to elute
t0 is the time taken for the mobile phase to pass
through the column.
Figure 9 shwoing the diagram of capacity factor for HPLC
performance (Greay, 2016)
Resolution
The distance between two neighbouring peaks
Rs = (tR2 – tR1) / ((0.5 * (w1 + w2)) (1)
Figure 10 showing the resolution of 2 neighbouring peak
(Greay, 2016)
Efficiency Number plates: This is used to check how efficiency the column is. If the theoretical plate,
the retention time reduces and it is faster
25. Gas Chromatography -Mass spectrometry
Gas chromatography is a technique that involve the partition of analyte in the gaseous phase.
The mobile phase in GC is an inert gas (usually hydrogen, nitrogen or helium) and its functions
is to transport the analyte through the column. The stationary phase can be solid or liquid and
this is usually suspended unto the column housed in an oven. The purpose of the stationary
phase is to interact with the components of the mobile phase and this interaction results to
separation of analyte (University, n.d.). A schematic of a basic GC chromatograph is outlined
in figure 11.
Figure 11 A schematic diagram of GC chromatogram. (University, n.d.)
The introduction of a sample into the GC is done by a sample injection system which includes
an auto sampler, solvent and waste vials, a micro-syringe injector and a heated inlet. The
temperature of the inlet is usually 50°C above the boiling point of the least volatile component
of the sample. This ensures that the sample is introduced onto the column in a small narrow
volume and then goes to the detector for signals.
Mass spectrometry is usually coupled with GC and LC chromatography. The mass
spectrometer is an instrument which can measure the masses and relative concentrations of
atoms and molecules.
How does a mass spectrometer work?
1. Introduction
2. Sample introduction
3. Methods of sample ionisation
4. Analysis and separation of sample ions (Ashcroft, n.d.)
5. Detection and recording of sample ions
26. Methods of Analysis Methylxanthines in food
Many methods exist for determining the methylxanthines content of food and beverages. Some
of these methods include UV-Visible spectrophotometry, High-Performance Chromatography,
Gas chromatography, ion chromatography, capillary electrophoresis, micellar capillary
electrophoresis, gas chromatography, and solid-phase microextraction gas chromatography.
(Igelige Gerald, 2014) HPLC is the most commonly used analytical methods. This section
discusses highlight the uses of the different technique, methodology studies that involve the
analysis of methylxanthines in food products.
(Magalhães, Luis M; Machado, Sandia; Marcela, Segundo A; Lopes, Joao A; Pascoa, Ricardo
N.M.J, 2016)One study demonstrated using an FT-NIR spectroscopy method with an HPLC
coupled with diode-array detection to analyse 61 spent coffee ground samples.
Chromatographic separation of Ground coffee was ethanol/water (50/50, v/v) extract was
performed. The HPLC system used is (Jasco, Easton,USA)comprised of high-pressure
pump(PU-2089 PLUS0)equipped with reversed phase core-shell column to a photodiode array
detector. Within 30mins, the ground coffee is separated by an ethanol/water gradient. The main
of the experiment was to qualify major phenolic and methylxanthines present in the ground
coffee. The major phenolic found are (catechin, caffeic acid and chlorogenic) and
methylxanthine is (Caffeine and theophylline). Caffeine content was found the higher
concentration. Caffeine concentrations ranged from 740 to 12,400mg/kg of spent coffee
ground. Chlorogenic acid ranged from 157 to 3593mg/kg of spent coffee ground. The NIR
spectra of spent coffee ground samples were analysed using PCA model (Principal component
analysis). The near –Infrared spectroscopy was proposed as a rapid and none – destructive
technique to assess the content of three main phenolics and methylxanthine. PCA models using
NIR spectra samples were performed for the screening of possible outliers through squared
27. residuals statistics. All the compound was modelled in separate ways using PLS (Partial least
squares regression).For caffeine PLS model, the wavenumbers with the highest contribution
were 5945,4890,4500,4430 and 4145cm-1.
The first overtones region (N-H and C-H bond first
overtones) and could be associated with caffeine. The absorption at 4890cm-1
is related to the
C=O bond combined with N-H bond. CH3 bond absorption is 4500cm-1
and 4430cm-1
and the
CH bond combination occurs at 41545cm-1
. The Theophylline PLS models highest
wavenumbers are 4945, 4870, 4510, 4445, 4410 and 4380cm-1
. The N-H and C=O bond stretch
are 4945, 4870cm-1
and the CH3bond stretch are 4510, 4445, 4410, 4380cm-1
. (Magalhães, Luis
M; Machado, Sandia; Marcela, Segundo A; Lopes, Joao A; Pascoa, Ricardo N.M.J, 2016)
(João Rodrigo Santos, 2012) applied a chromatographic low-pressure flow injection system for
the of methylxanthines in coffee. In this work, the coupling of commercial monoliyhiccoulmn
to a traditional low-pressure flow rate injection system was proposed for the analysis of
theobromine, theophylline and caffeine in coffee brewed samples using UV detector set at
273nm. The flow system performance was studied at room temperature by increasing the
peristaltic pump for rotation using a mobile phase acetonitrile: water, 3:97, v/v up to maximum
value of 2.5mLmin-1
. Different compositions of mobile phase solution mixture of acetonitrile:
water were tested to achieve a good separation between theobromine, theophylline, and
caffeine. The different flow rate was tested at 0.65, 0.85 and 1.06mLmin-1
.A linear dependence
between peristaltic pump rotation speed and flow rate within the range. (João Rodrigo Santos,
2012)
The resolution values for theobromine and theophylline signal are within 1.88 and 2
(Mashkouri, Nahid Najafi; Hamid, Ahmadi Seyed; Afshin, Khorrami Rajabi, 2003) quantitated
the caffeine existing in black tea leaves based on the method of Fourier transform(FTIR)
spectroscopy using multiple linear regression. The caffeine was extracted using CHCl2 from
28. black tea leaves, wetted with an aqueous solution of NH3 solution. The spectroscopic data was
obtained at a wavenumber range of 1800-1300cm-1
with a micro flow cell with CaF windows
and path length of 0.518mm by accumulating 20 scans with the resolution of 4cm-1
. The method
had a detection limit of 35µg/mL, the sampling frequency of 6 h-1
and a coefficient of variation
of 0.8% for five independent measurements of tea samples of 3.68% w/w caffeine content.
Based on the results obtained by the authors, the caffeine content from FTIR (3.68±0.03% w/w)
and reference HPLC technique (3.60±0.07% w/w) provides similar results for caffeine. FTIR
has a better-developed method for determining caffeine in tea leaves through it precision,
accuracy, and quickness. (Mashkouri, Nahid Najafi; Hamid, Ahmadi Seyed; Afshin, Khorrami
Rajabi, 2003).
Another spectrometry based methodology (Solid phase Fourier transform- Raman
spectrometry, SP-FT-Raman) was developed for determination of caffeine in commercial
energy drinks. Raman spectrometer is equipped with C18bonded silica with average particle
size of 105 and 50-70um.A Gilson Minipuls P2 peristaltic pump and 1 mm i.d tygon pump tube
and PTFE 0.8 mm i.d. connecting tubes were used to introduce the sample. The caffeine content
of each sample was determined from Raman intensify between 573 and 542cm-1
with a
corrected baseline between 580-540cm-1
. The limit of detection of SP-FT-Raman method was
obtained at 18mg 1h-1
, with a repeatability of 3% as the relative standard deviation of five
analysis of 200mg 1-1
concentration of caffeine. FT-Raman coupled with solid-phase this
enhanced and increased the sensitivity of detecting caffeine by a factor of 31 times when
compared with Raman measurement alone. The SP-FT-Raman provides a sampling frequency
of 13.3 h−1
, higher than that of liquid chromatography (LC), which was 7.0 h−1
. (Sergio, et al.,
2005)
30. Materials
All chemicals used were of analytical grade; Caffeine, Theobromine and theophylline were
obtained from Sigma Aldrich, HPLC grade methanol was obtained from Sigma Aldrich
.Ultra-pure water (Milli Q water) obtained from analytical laboratory LIT.
Samples: Cadbury Bournville Cocoa Powder, Barry’s Tea Gold Blend Tea bags, Maxwell
Spouse Rich Blend Coffee were obtained from local supermarket,
A SPE vacuum system, an HPLC –UV system with C, an HPLC –UV system with C18
column and A GC-Mass spectrometry.
Preparation of mobile phase
1 litre of beaker was used to measure 600mL of ultra-pure water and 400mL of methanol to
achieve 60:40% water: methanol. This was made up in 1litre of volumetric flask. The
solution was filtered through a 0.45um nylon filter. The solution was stored in a mobile phase
storage bottle.
Preparation of Caffeine
10mg of caffeine was weighed out using an electric balance and this was transferred into a
100mL volumetric flask. The mobile phase in 2.2 was used to dissolve the caffeine and made
up to the mark. Sonication was applied to completely dissolve the caffeine and was labelled
the stock solution. From the stock solution, 10ml of stock solution into 100mL making
100ppm and this was labelled as the working stock. Five standards were made from the
working standard from 10ppm to 100ppm concentration of caffeine.
Preparation of Theobromine
Experimental procedure for the determination of caffeine at 2.3 is used for theobromine sand
theophylline.
Sample Preparation
0.5g of Cocoa powder was dissolved in ultra-pure water. The solution was left to heat up for
about 15mins at 80°C in a water bath. After the sample have been heated. The sample was
placed on sequential conditioning of SPE tube. Firstly, the SPE tube in the vacuum was
conditioning with 1mL methanol for activation and after wards 1mL of ultra-pure water for
Equilibration.
The second step is loading the sample; 0.5mL of cocoa was loaded into the SPE tube, the third
step was washing all the cocoa into the tube using 1mL of ultra- pure water. The fourth step is
31. elute the compound needed from the cocoa. 2 times with 2.5mL of methanol was used to elute
the compounds and the second elution was placed on different vial.
The eluted compound was characterised using HPLC.
All the other samples (Coffee and Tea0 undergo the same procedure as 2.5).
Instrument
2.6.1 HPLC
Automated Liquid Chromatography
Mobile phase: H2O: Methanol 60:40%
Flow rate: 1.0ml/min
Column: 150×4.6mm, 5-um particle size
Retentions time: 10minutes
Wavelength: 275nm
Injection volume: 10ul
Temperature: 25
2.6.2 GC-Mass spectrometry
See the Appendix for the method for GC-Mass for Caffeine.
33. Validation of the Chromatographic Method
3.1.1 Linearity and Range
The linearity of the method was tested to demonstrate a direct proportional relationship of
response (Area) versus caffeine concentration over working range. The FDA guideless
specified a minimum of five concentration levels with the acceptance criteria linear regression
coefficient should be greater than or equal to 0.995. From the excel linearity of caffeine, the R2
value obtained is 0.998. From regression line, there is an excellent relationship between the
Peak area and concentration of caffeine shown in figure. The data obtained from linearity
experiment are presented in figure.
Table T: showing the linearity of caffeine standards
Figure 12: Showing the graph linearity of caffeine standards.
y = 28.341x + 11.333
R² = 0.998
0
500
1000
1500
2000
2500
3000
3500
0 20 40 60 80 100 120
PeakArea
Concentration in ppme
A linearity realationship of Peak Area verus the Caffeine
Concentration
Standard concentration 20ppm 40 60 80 100
1 644.1326 1113.493 1644.223 2307.699 2863.823
2 642.8065 1114.525 1643.076 2314.959 2861.409
3 642.2367 1112.266 1641.667 2308.696 2857.434
4 643.1059 1110.955 1641.633 2310.67 2862.757
Average 643.0704 1112.81 1642.65 2310.506 2861.356
Standard deviation 0.794601 1.543085 1.245783 3.215384 2.79457
%RSD 0.12356 0.138665 0.075839 0.139163 0.09766
34. 3.1.2 Precision – percentage RSD value
Standard
Concentration
(60ppm)
Injection
number
Peak Retention
time
Area Height
1 1 Caffeine 3.175 1641.66724 249.24017
2 2 Caffeine 3.165 1643.07500 251.93997
3 3 Caffeine 3.165 1644.22290 253.71841
4 4 Caffeine 3.162 1641.63281 250.34247
5 5 Caffeine 3.162 1641.79968 250.92393
6 6 Caffeine 3.163 1643.94043 251.18338
Mean 1642.72301
SD 1.18417929
%RSD 0.07%
Table 5: Showing the Precision of Caffeine standard on HPLC
Repeatability Precision: The values of relative standard deviation of six replicate injections of
the standard solutions lie well within the limit (%RSD ≤ 0.07), indicating the injection
repeatability of the method (Table). The repeatability results was taken over a short period of
time under the same conditions. The acceptance criteria for an assay method for instrument
should be %RSD≤1. The value obtained from table is %RSD ≤ 0.07.
3.1.3 Accuracy
35. Table
6:showing the Accuracy method validation of caffeine using HPLC instrument.
The next validation carried out was accuracy. This test use the same data as the linearity and
precision in six replicates of standard 20ppm- 100ppm were injected into the HPLC system
and data obtained were analysed.
Standard concentration 20ppm 40 60 80 100
1 644.1326 1113.493 1644.223 2307.699 2863.823
2 642.8065 1114.525 1643.076 2314.959 2861.409
3 642.2367 1112.266 1641.667 2308.696 2857.434
4 643.1059 1110.955 1641.633 2310.67 2862.757
Average 643.0704 1112.81 1642.65 2310.506 2861.356
Standard deviation 0.794601 1.543085 1.245783 3.215384 2.79457
%RSD 0.12356 0.138665 0.075839 0.139163 0.09766
% Recovery 20ppm 40ppm 60ppm 80ppm 100ppm
1 110% 98% 96% 101% 100%
2 110% 98% 96% 101% 100%
3 111% 97% 96% 101% 100%
4 110% 97% 96% 101% 100%
36. 3.1.4 Limit of Detection
The limit of detection is the lowest amount of an analyte to be detected by the method
developed. The signal to noise must be 3:1
The baseline noise height from the blank = 0.7 cm
S= signalled obtained from the peak = 2.5
S/N = 2.5/0.7 = 3.28
The LOD is 3.28
Figure 13 Blank of the solution (mobile phase)
Figure 14-Limit of detection of Caffeine
37. 3.1.5 Limit of Quantification
The limit of Quantification is the lowest amount of analyte to be quantified by the method.
The signal nosed is 10:1
The baseline noise height from the blank is = 0.7cm
The signaed obtained from the peak = 5.822
S/N = 5.822/ 0.7 = 8.317
LOQ is 8.317
Figure 15 Limit of Quantitation of Caffeine solution.
38. 3.1.6 Specificity
Specify is the ability to distinguish an analyte using a chromatogram.
The chromatogram showed below is Caffeine
Figure 16the chromatogram of Caffeine
Caffeine is showed with the retention value of 3.064 minutes
40. Discussion
Method development and validation of Caffeine
Method development has to be validated. Method development involves a strategic approach
to an analytical problem through numerous ways. Before separation of any analysis,
information (physical and chemical properties) of the compounds interest must be gathered.
On figure 1 the chemical structures of theobromine, theophylline and caffeine are showed.
From the structure it was showed that methylxathines have similar structure; they only differ
due to the position of CH3 and NH.
After the knowledge based is established from an initial experiment protocol of a literature on
the methylxanthines. In this research a method development for caffeine was carried out
successfully. The chosen mobile phase was a mixtures of Water and Methanol in a 60: 40
composition. The column used was a Hichrom NC100-5C18-1723(150×4.6mm, 5-um particle
size) reversed phase column and detector was a UV-VIS absorbance detector. The caffeine
standards were ranged from 20 to 100ppm. The ideal HPLC conditions are
HPLC Conditions
Automated Liquid Chromatography
Mobile phase: H2O: Methanol 60:40%
Flow rate: 1.0ml/min
Column: 150×4.6mm, 5-um particle size
Retentions time: 10minutes
Wavelength: 275nm
Injection volume: 10ul
Temperature: 25
The ICH guidelines give a description on how to carry out each test and the acceptance criteria
which must be met.
Under this Conditions,
Linearity,
Precision,
Accuracy,
Specificity,
Limit of Detection
Limit of Quantitative.
41. From the test carried out in Method validation section, it was concluded that the method for
the analysis of Caffeine and Methylxanthines was validated successfully as all the results
obtained within the requirements set out by the ICH.
Before the method was validated, series of tests were carried out using different composition
of mobile phase and different flow rate. Hichrom NC100-5C18-1723(150×4.6mm, 5-um
particle size), the conditions used for this initial attempt consisted of 90%:10% composition of
water/menthol, column temperature of 25°C flow rate of 0.8ml/min, and UV detection
wavelength of 274nm. The figure (17) below shows the peak obtained from the HPLC
conditions outlined. From the peak, it was observed that the peak was broad due to the mobile
phase composition and the flow rate. Using sigma Aldrich HPLC troubleshooting guide, it was
understood from there that I need to change the composition of mobile phase and mobile phase
flow rate is too low.
Figure 17showing the HPLC analysis of caffeine at a concentration of 20ppm with a Hichrom
NC100-5C18-1723(150×4.6mm, 5-um particle size) column and HPLC conditions of 95%
water: 10% methanol, flow rate of 0.8ml/min, column temperature of 25°C and a UV
wavelength of 273.compound labelled.
42. The variations were mobile phase and flow rate. The flow rate was adjusted from 0.8ml/min to
1.0ml/min and the mobile phase was changed from water/methanol 90:10% to 69:40%
composition. As the conditions were changed, the peak became more shaper with shorter
retention time. The adjusted conditions for the analysis of caffeine is shown below in figure ()
Figure 18 showing the HPLC analysis of caffeine at a concentration of 20ppm with a Hichrom
NC100-5C18-1723(150×4.6mm, 5-um particle size) column and HPLC conditions of 60%
water: 40% methanol, flow rate of 1.0ml/min, column temperature of 25°C and a UV
wavelength of 273.compound labelled.
Once the method for the analysis of Caffeine was developed and validated, it was decided that
the method should be use to separate methylxanthines. Before separation, the standards of
theophylline and theobromine were ran on HPLC with the same conditions as caffeine.
The chromatograms below showed the standards of theophylline and theobromine.
43. Figure 19 showing the HPLC analysis of theobromine at a concentration of 20ppm with a
Hichrom NC100-5C18-1723(150×4.6mm, 5-um particle size) column and HPLC conditions
of 60% water: 40% methanol, flow rate of 1.0ml/min, column temperature of 25°C and a UV
wavelength of 273.compound labelled.
Figure 20 showing the HPLC analysis of theophylline at a concentration of 20ppm with a
Hichrom NC100-5C18-1723(150×4.6mm, 5-um particle size) column and HPLC conditions
of 60% water: 40% methanol, flow rate of 1.0ml/min, column temperature of 25°C and a UV
wavelength of 273.compound labelled.
44. After the methylxanthines have been analysed separately on RP-HPLC, the retention time of
the three compounds were obtained. From the introduction, we were ask how we can separate
the three compounds. The diagram below showed the separation of the three methylxanthine
standards using the same HPLC parameters as above.
Figure 21showing the separation of methylxanthines at a concentration of 100ppm with a Hichrom
NC100-5C18-1723(150×4.6mm, 5-um particle size) column and HPLC conditions of 60%
water: 40% methanol, flow rate of 1.0ml/min, column temperature of 25°C and a UV
wavelength of 273.compound labelled.
Based on this chromatogram, it shows that theobromine came out first followed by theophylline
and the caffeine. The elution of all this compounds is based on their structure properties. As
explained in the introduction about log P. log P explains how to measure an analyte partitions
between the immiscible. The log P of theobromine was found to be -0.78, the Log P of
theophylline is found to be -0.77 and caffeine was found to be -0.55. From the log P
theobromine is more polar than theophylline and caffeine. More polar molecule elute faster
than less polar. Also it explained that the higher the log P, the more hydrophobic the molecule.
Hydrophobic is non-polar.
After gathering all the information on different parameters for the analysis of methylxanthines,
a full standards on different concentrations of theobromine, theophylline and caffeine is done
45. to check for the system suitability. On the each standards, the theoretical plates and tailing
factor were put into consideration before analysing it on samples.
Theobromine
standards
concentrations
Retention time in
seconds
Width of the
peak in second
Theoretical plate
number
Tailing Factor
20ppm 126.9 4.884 10,801.70 1
30ppm 126.84 4.800 11,172.49 1
50ppm 126.9 4.77 11,324.17 1
100ppm 126.9 4.728 11,526.26 1
Table 7showing the standard concentrations of theobromine with the theoretical plate number
and tailing factor.
Theophylline
standards
concentrations
Retention time in
seconds
Width of the
peak in second
Theoretical plate
number
Tailing Factor
20ppm 160.56 5.424 14,020.24 1
30ppm 160.50 5.382 14,229.27 1
50ppm 160.26 5.34 14,410.79 1
100ppm 160.02 5.262 14,796.77 1
Table 8showing the standard concentrations of theobromine with the theoretical plate number
and tailing factor
Caffeine standards
concentrations
Retention time in
seconds
Width of the
peak in second
Theoretical plate
number
Tailing Factor
20ppm 183.84 5.898 15,544.99 1
30ppm 183.84 5.904 15,513.41 1
50ppm 183.96 5.82 15,985.30 1
100ppm 183.90 5.82 15,974.88 1
Table 9: showing the standard concentrations of theobromine with the theoretical plate number
and tailing factor
From the FDA, the acceptance criteria should be > 2000. From the tables above it showed
that the theoretical plate number is greater than 2000. This shows that the column is
efficiency, the factors that can affect the N is flow rate of the mobile phase, particle size in
column, and these have been corrected. Also the tailing factor for each standards is 1, the
FDA acceptance criteria should be < 2. This system is acceptable for the analysis of samples.
46. Sample
Cocoa powder (Bourville),
Coffee powder (Richman
blend) and Tea bags
(Barry’s gold) were
analysed on RP-HPLC
using the same conditions
as the standards.
Cocoa sample analysed on
RP-HPLC. It was
observed that there is a lot
of theobromine in cocoa
and just traces of caffeine and theophylline in cocoa.
Figure 22 showing the cocoa extract using HPLC with the same above HPLC conditions
Coffee sample
anaysised on RP-
HPLC to obsereve if
there is any
methylxanthines. It
was observed that
there is no
theophylline in
coffee sample
Figure 23: showing the Coffee sample extract using the same above HPLC condtions
47. Tea bags was analysed
on RP-HPLC using the
same condition above
It was observed that
there just traces of
theophylline in tea bags
Figure 24: showing the Tea extract using HPLC with the same HPLC conditions above
Quantitative Analysis
Three different samples Cocoa, Coffee and Tea bags of theobromine, theophylline and
caffeine has been quantified in this project. Results of the quantitative of three extracts per
sample are shown in Table ().
Ingredient Cocoa in 100g of
sample
Coffee in 100g of
sample
Tea in 100g of
sample
Theobromine 1.5g 0.5622g 0.338g
Theophylline Trace - Trace
Caffeine 0.05788g 1.2g 0.7554
Table 10: showing the amount of methylxanthine in each samples analysed
.
48. Gas Chromatography
Caffeine was analysed on Gas chromatography. The method development has already been
validated by the technical in Limerick Institute of Technology.
Gas Chromatography separate compounds based on the boiling point. The lower the boiling
point, the more polar the compound it is on the GC, the faster the retention time.
The chromatogram is the mixtures of methylxathaines and it was analysed on GC –Mass
spectrometry.
Figure 25: showing the sepration of Methylxanthine on GC-mass spectrometry
From the chromatogram, it was observed that Caffeine elute out first, based on the boiling
point, the boiling point of caffeine is 178°C, the boiling point for theobromine is 357°C and
the theophylline boing point is 454°C. Based from the boiling point, Caffeine has the lowest
boiling point a caffeine elute out first followed by theobromine and the last is theophylline.
49. The chromatogram outlined can be identified through the mass spectrometry, the figure
below is the mass spectrometry of the mixtures. To identify the compound, the use of the
molecular weight is used to obtain the compounds from the chromatogram.
The first fragment is caffeine, Caffeine has a molecular weight of 194g/mol.
Figure 27: showing the caffeine from the coffee sample.
Figure 26: showing the spectrum of the Caffeine from Mass- spectrometry
50. Figure 28: showing the fragment of Theobromine in the mass spectrum of the mixtures
51. 5 Conclusion
The main goal for this project was to develop a method using HPLC system and also to
determine Methylxanthine. The method was developed for the analysis of methlyxanthine
and validated according to FDA.
This project focused on the determination of methylxanthine using HPLC system. The SPE
extraction for the sample were successfully extracted .
The validated HPLC method for the quantification caffeine, theobromine and theophylline in
beverages was found to be sensitive and precise.
Cocoa powder was found to contain Theobromine mostly in the container, about 1.5g.
6 Future work
If this project was to be done again, some more tests and analysis is suggested, for example
more work to be done for the GAS chromatography mass spectroscopy. I found it interesting
but there was not enough time to go further on the analsying of methylxanthine using GC-mass
Spectrometry.
Also the use of automated SPE will be a great advantage
52. 7 Calculations
Theobromine
Concentration of Theobromine
standards
Peak Area of Theobromine
standards
0 0
10 332.85
20 440.57
30 904.51
50 1617.96
100 3087.03
Cocoa sample 2344.80
Coffee sample 847.65
Tea sample 579.56
Figure –Standard curve for caffeine as analysed by HPLC using C-18 columns and 60%/40%(
v/v) water and methanol as mobile phase detected at 275nm.
From the graph, the equation line is
Y = 31.37x-34.131
y = 31.37x - 34.131
R² = 0.9947
-500
0
500
1000
1500
2000
2500
3000
3500
0 20 40 60 80 100 120
Theobromine
53. From the table,
System Suitability Results
Theoretical number is calculated for theobromine standards using the USP method at 10ppm
concentration
N= 16(Ve/ Wb)2
N = number of the theoretical plates
Ve= Retention time
Wb= Width of the peak at half peak height
N = 16 (
126.96
4.98
)
2
= 10,399.08
From others concentration the theoretical plates and Tailing factor are
Theobromine
standards
concentrations
Retention time
in seconds
Width of the
peak in second
Theoretical
plate number
Tailing
Factor
20ppm 126.9 4.884 10,801.70 1
30ppm 126.84 4.800 11,172.49 1
50ppm 126.9 4.77 11,324.17 1
100ppm 126.9 4.728 11,526.26 1
Tailing factor
Tailing Factor is calculated for theobromine standards using the USP method at 10ppm
concentration
T = (A+B)/2A.
T = tailing factor (measured at 5% of peak height)
b = distance from the point at peak midpoint to the trailing edge
a = distance from the leading edge of the peak to the midpoint
A = 0.4
54. B = 0.4
T = (
0.4+04
2(0.4)
) = 1
Theoretical number
Theoretical number for cocoa sample is calculated to be
N = 16 (
126.72
5.214
)
2
= 9450.79
The tailing factor
Tailing factor for the sample is
A = 0.25
B = 0.25
T = (
0.3+0.3
2(0.3)
) = 1
Resolution
Resolution between the peak 1 and peak 2
Peak 1 = theobromine
Peak 2 = caffeine
Rs = (tR2 – tR1) / ((0.5 * (w1 + w2)) (1)
Tr1 = 2.112, Tr2= 3.040, W1= 0.6, W2 = 0.5
Rs=
3.040−2.112
0.5(0.5+0.6)(1)
= 1.68 = 1.7
Retention Factor
K =
𝑡𝑅−𝑡𝑂
𝑡𝑂
tR= Retention time
55. tM = time taken for the mobile phase to pass through the column.
K =
2.112−0.75
0.75
= 1.816
Cocoa peak area = 2344.80
The sample peak area is obtained, the absolute amount of the sample is calculated as follows:
Y = 31.37x-34.131
Interpolated amount(x) = 𝑥 =
2344.80+34.131
31.37
= 75.83ppm concentration of theobromine
From the SPE extraction,
The original dilution factor from 20ml of sample solution took 0.5ml of solution into SPE is 40
dilution factor.
1 HPLC vial contains 2.5ml of elution.
75.83ppm solution of theobromine in 2.5ml vial elution
75.83mg 1000ml
75.83
1000
× 2.5 × 40 0.5g of sample
7.5mg of theobromine in 0.5g of cocoa.
From the Bonriville 100g cocoa powder,
1 g of cocoa powder = 15mg of theobromine
In 100g of cocoa powder there is 1.5g of theobromine.
56. Coffee peak area = 2344.80
The sample peak area is obtained, the absolute amount of the sample is calculated as follows:
Y = 31.37x-34.131
Interpolated amount(x) = 𝑥 =
847.65+34.131
31.37
= 28.11ppm concentration of theobromine
From the SPE extraction,
The original dilution factor from 20ml of sample solution took 0.5ml of solution into SPE is 40 dilution
factor.
1 HPLC vial contains 2.5ml of elution.
28.11ppm solution of theobromine in 2.5ml vial elution
28.11mg 1000ml
28.11
1000
× 2.5 × 40 0.5g of sample
2.811mg of theobromine in 0.5g of coffee sample.
From the Richman blend 100g coffee powder,
1 g of coffee powder = 5.622mg of theobromine
In 100g of coffee powder there is 0.5622g of theobromine.
57. Theophylline
Concentration of Theophylline
standards
Peak Area of Theophylline
standards
0 0
10 445.2551
20 911.1568
30 1313.886
50 2293.057
100 3928.322
Cocoa sample 18.79980
Coffee sample -
Tea sample -
Figure –Standard curve for Theophylline as analysed by HPLC using C-18 columns and
60%/40 %( v/v) water and methanol as mobile phase detected at 275nm.
From the graph, the equation line is
Y = 39.446x+101.35
From the table,
y = 39.446x + 101.35
R² = 0.9926
0
500
1000
1500
2000
2500
3000
3500
4000
4500
0 20 40 60 80 100 120
AreaPeak
Concentration (ppm)
Theophylline
58. System Suitability Results
Theoretical number is calculated for theobromine standards using the USP method at 10ppm
concentration
N= 16(Ve/ Wb)2
N = number of the theoretical plates
Ve= Retention time
Wb= Width of the peak at half peak height
N = 16 (
160.44
5.466
)
2
= 13784.91
From others concentration the theoretical plates and Tailing factor are
Theophylline
standards
concentrations
Retention time
in seconds
Width of the
peak in second
Theoretical
plate number
Tailing
Factor
20ppm 160.56 5.424 14020.24 1
30ppm 160.50 5.382 14229.27 1
50ppm 160.26 5.34 14410.79 1
100ppm 160.02 5.262 14796.77 1
Tailing factor
Tailing Factor is calculated for theophylline standards using the USP method at 10ppm
concentration
T = (A+B)/2A.
T = tailing factor (measured at 5% of peak height)
b = distance from the point at peak midpoint to the trailing edge
a = distance from the leading edge of the peak to the midpoint
A = 0.4
B = 0.4
T = (
0.4+04
2(0.4)
) = 1
59. Caffeine
0 0
10 350.5
20 741.66
30 1063.4
50 1984.98
100 3443.49
Cocoa sample 144.49
Coffee sample 105.61
Tea sample 1360.73
Figure –Standard curve for caffeine as analysed by HPLC using C-18 columns and 60%/40%(
v/v) water and methanol as mobile phase detected at 275nm.
From the graph, the equation line is
Y = 34.87x + 43.562
From the table,
y = 34.87x + 43.562
R² = 0.9936
0
500
1000
1500
2000
2500
3000
3500
4000
0 20 40 60 80 100 120
AreaPeak
Concnetration(ppm0
Caffeine standards
60. System Suitability Results
Theoretical number is calculated for Caffeine standards using the USP method at 10ppm
concentration
N= 16(Ve/ Wb)2
N = number of the theoretical plates
Ve= Retention time
Wb= Width of the peak at half peak height
N = 16 (
184.32
6.03
)
2
= 14949.62
From others concentration the theoretical plates are
Caffeine standards
concentrations
Retention time in
seconds
Width of the peak
in second
Theoretical plate
number
20ppm 183.84 5.898 15,544.99
30ppm 183.84 5.904 15,513.41
50ppm 183.96 5.82 15,985.30
100ppm 183.90 5.82 15,974.88
Tailing factor
Tailing Factor is calculated for Caffeine standards using the USP method at 10ppm
concentration
T = (A+B)/2A.
T = tailing factor (measured at 5% of peak height)
b = distance from the point at peak midpoint to the trailing edge
a = distance from the leading edge of the peak to the midpoint
A = 0.4
B = 0.4
T = (
0.4+04
2(0.4)
) = 1
61. Cocoa peak area = 144.49.
The sample peak area is obtained, the absolute amount of the sample is calculated as follows:
Y = 34.87x + 43.562
Interpolated amount(x) = 𝑥 =
144.4875−43.562
34.87
= 2.894ppm concentration of caffeine
From the SPE extraction,
The original dilution factor from 20ml of sample solution took 0.5ml of solution into SPE is 40
dilution factor.
1 HPLC vial contains 2.5ml of elution.
2.894ppm solution of theobromine in 2.5ml vial elution
2.894mg 1000ml
2.894
1000
× 2.5 × 40 0.2894g of sample
0.2894mg of caffeine in 0.5g of cocoa.
From the Bonville 100g cocoa powder,
1 g of cocoa powder = 0.5788mg of caffeine
In 100g of cocoa powder there is 0.05788g of caffeine.
62. Theoretical number for cocoa sample
Theoretical number for cocoa sample is calculated to be
N = 16 (
182.4
6.36
)
2
= 13,159.99
The tailing factor Tailing factor for the sample is
A = 0.25
B = 0.25
T = (
0.25+0.25
2(0.5)
) = 0.5
Resolution
Resolution between the peak 1 and peak 2
Peak 1 = theobromine
Peak 2 = caffeine
Rs = (tR2 – tR1) / ((0.5 * (w1 + w2)) (1)
Tr1 = 2.112, Tr2= 3.040, W1= 0.6, W2 = 0.5
Rs=
3.040−2.112
0.5(0.5+0.6)(1)
= 1.68 = 1.7
Retention Factor
K =
𝑡𝑅−𝑡𝑂
𝑡𝑂
tR= Retention time
tM = time taken for the mobile phase to pass through the column.
K =
3.040−0.75
0.75
= 3.05
63. Coffee samples
From Maxwell house rich blend products
The sample peak area is obtained, the absolute amount of the sample is calculated as follows:
2221.26 = 34.87x + 43.562
Interpolated amount(x) = 𝑥 =
2221.26−43.562
34.87
= 62.452ppm concentration of caffeine
From the SPE extraction,
The original dilution factor from 20ml of sample solution took 0.5ml of solution into SPE is 40
dilution factor.
1 HPLC vial contains 2.5ml of elution.
62.452ppm solution of theobromine in 2.5ml vial elution
62.452mg 1000ml
62.452
1000
× 2.5 × 40 6.2452g of sample
6.2452mg of caffeine in 0.5g of coffee.
From the Maxwell house rich 100g coffee,
1 g of coffee = 12mg of caffeine
In 100g of cocoa powder there is 1.2g of caffeine
64. Tea samples
From Barry’s tea gold blend.
The sample peak area is obtained, the absolute amount of the sample is calculated as follows:
1360.73= 34.87x + 43.562
Interpolated amount(x) = 𝑥 =
1360.73−43.562
34.87
= 37.77ppm concentration of coffee in 0.5ml.
From the SPE extraction,
The original dilution factor from 20ml of sample solution took 0.5ml of solution into SPE is 40
dilution factor.
1 HPLC vial contains 2.5ml of elution.
37.77ppm solution of theobromine in 2.5ml vial elution
37.77mg 1000ml
62.452
1000
× 2.5 × 40 3.777mg of sample
3.777mg of caffeine in 0.5g of tea.
From the Barry tea bag 100g,
1 g of Barry tea bag = 7.554mg of caffeine
In 100g of Barry tea bag, there is 0.7554g of caffeine
65. 8 References
Clark, I. & Landolt, H. P., 2015. Coffee, caffeine, and sleep: A systematic review of epidemiological
studies and randomized controlled trials. Elsvier journal, pp. 1-9.
Ashcroft, D. A. E., n.d. An Introduction to Mass Spectrometry, Leeds: s.n.
B.Fredholm, B., 2011. Pharamacokinetic and Metabolism o fNatural Methylxanthines in Aninal and
Man. Handbook of Experimental Pharamacology, Volume 200, p. 36.
Bennett Alan Weinberg and Bonnie K. Bealer, 2016. World of caffeine. [Online]
Available at: http://worldofcaffeine.com/controlling-pain/
Books, H., 2016. Wikicaffeine. [Online]
Available at: https://en.wikipedia.org/wiki/Caffeine
[Accessed 17 05 2016].
cutris, S., 2016. SPE lecture notes. Limerick Institue Of thechnology : s.n.
Douglas, F., n.d. GC/MS Analysis, s.l.: Scientific Testimomny .
E. M. Thurman, M. S. M., 2016. WikiSPE. [Online]
Available at:
https://www.google.ie/search?q=spe+extraction&espv=2&biw=1024&bih=667&site=webhp&source
=lnms&tbm=isch&sa=X&ved=0ahUKEwiokpWa8-
XMAhXMD8AKHQFYDBEQ_AUIBigB#imgrc=m29jiK9azdSbaM%3A
[Accessed 17 05 2016].
Greay, M., 2016. Liqiud Chromatography lecture notes. Limerick: Limerick Instiurtue of Technology.
Group, W. R., 2007. Drugbank. [Online]
Available at: http://www.drugbank.ca/drugs/DB01412
[Accessed 17 05 2016].
Health, W. K., 2009. Drugs.com. [Online]
Available at: http://www.drugs.com/npp/cocoa.html
[Accessed 25th March 2016].
Henry Vandyke Carter, H. G., 1918. Wiki Theobromine. [Online]
Available at: https://en.wikipedia.org/wiki/Theobromine#/media/File:Gray961.png
[Accessed 17 05 2016].
Igelige Gerald, D. E. A. a. A. A., 2014. Determination of CaffeineIn Beverages. American Journal of
Engineering Research (AJER), 3(8), pp. 124-137.
João Rodrigo Santos, A. O. R., 2012. Development of a chromatographic low pressure flow injection
system:Application to the anaysis of methylxanthine in coffee. Analytical Chimica Acta , Volume 715,
pp. 57-63.
66. Labcompare, 2009. Labcompare. [Online]
Available at: www.labcompare.com
[Accessed 30 march 2016].
Magalhães, Luis M; Machado, Sandia; Marcela, Segundo A; Lopes, Joao A; Pascoa, Ricardo N.M.J,
2016. Rapid assessment of bioactive phenolics and methylxanthines in spent coffe grounds by FT-NIR
spectroscopy. Talanta, Issue 147, pp. 460-467.
Mashkouri, Nahid Najafi; Hamid, Ahmadi Seyed; Afshin, Khorrami Rajabi, 2003. Determination of
caffeine in black tea leaves by Fourier transform infrared spectrometry using multiple linear
regression. Mircochemistry Journal, Issue 75, pp. 151-158.
P.J.Higson, S., 2004. High -Perfromance Liquid Chromatography . In: Anaytical Chemistry . Oxford:
University Press , p. 237.
Paradkar, M.M, and Irudayaraj, 2002. Rapid determination of caffeine content in soft drinksusing
FTIR-ATR spectrosco. Food Chemistry, Issue 78, pp. 261-266.
Rang, H., Dale, M., Ritter, J. & Flower, R., 2004. Drugs used in asthma. In: Phamarcology . Chichester,
England: John Wiley& sons Ltd, p. 345.
Ruben Vardanyan, V. H., 2016. Diuretics. Department of Chemistry and Biochemistry, University of
Arizona, pp. 317-327.
Saberi, H., 2010. Tea; A Globval History. London: Reaktion Books.
Scientific, C., 2013. Crawford Scientific. [Online]
Available at: http://www.crawfordscientific.com/Chromatography-Technical-Tips-Diode-Array-
Detector-Settings.html
[Accessed 11 04 2016].
Scientific, C., n.d. Chromaacademy. [Online]
Available at:
http://www.chromacademy.com/lms/sco5/Theory_Of_HPLC_Reverse_Phase_Chromatography.pdf
[Accessed 17 05 2016].
Sergio, A., Salvador , G. & Miguel , d. l. G., 2005. Solid-phase FT-Raman determination of caffeine in
energy drinks. Analytical Chimica Acta , 547(2), pp. 197-203.
Shu, Chem, n.d. Chem SHU. [Online]
Available at: http://hplc.chem.shu.edu/NEW/HPLC_Book/Introduction/int_typs.html
[Accessed 18th April 2016].
Tannenbanum, G., 1941. Chocolate: A Marvelous Natural Porduct of chemistry. Journal of Chemistry,
81(8), p. 1131.
Tavita, T. T., 2012. savalinews. [Online]
Available at: http://www.savalinews.com/2012/06/25/cocoa-coffee-projects-fruiting/
[Accessed 11 04 2016].
67. University, S. H., n.d. Teaching.shu.ac. [Online]
Available at: http://teaching.shu.ac.uk/hwb/chemistry/tutorials/chrom/gaschrm.htm
[Accessed 17 05 2016].
vine, t. &., 2015. Seed and Vine. [Online]
Available at: http://seedandvine.com/product/coffee-tree-arabica-coffea
[Accessed 17 05 2016].
Waters, 2006 . New Mexico State University (College of Arts and science). [Online]
Available at: http://web.nmsu.edu/~kburke/Instrumentation/Waters_HPLC_MS_TitlePg.html
[Accessed 11 04 2016].
WikiTea, 2016. wikipedia. [Online]
Available at: https://en.wikipedia.org/wiki/Tea
[Accessed 17 05 2016].
Yesair, D., Branfman, A. & Callahan, M., 1984. The Methylxanthine Beverages and Foods:
Chemistry,Cosumption and health effect. New York : Alan R. Liss.Inc .